Evidence-generation program

An evidence-generation program is a coordinated plan for producing clinical, real-world, and economic data to support the value and positioning of a pharmaceutical product.

What is an evidence-generation program?

An evidence-generation program is a strategic framework used to plan, develop, and deliver data that demonstrates the clinical effectiveness, safety, economic value, and real-world impact of a pharmaceutical product. It includes both pre- and post-launch activities and may involve clinical trials, real-world evidence (RWE) studies, observational research, health economics and outcomes research (HEOR), and patient-reported outcomes (PROs). Programs are typically tailored to the needs of key stakeholders such as regulators, payers, providers, and patients.

Why are evidence-generation programs important?

Evidence-generation programs enable pharmaceutical companies to build a comprehensive value story, address stakeholder evidence requirements, and support market access and reimbursement. By generating relevant and credible data throughout the product lifecycle, companies can inform clinical decision-making, enhance competitive positioning, and meet evolving expectations for transparency, patient-centered outcomes, and long-term impact.

HelixAI
Analyze your landscape in seconds with an AI-enhanced knowledge management...
Discover HelixAI
VISFO
Consulting
Optimize your strategic decision-making
Collaborate seamlessly, solve key challenges with proven strategic frameworks, and unlock deeper insights through precision intelligence.
Discover Consulting

See it in action with an interactive demo

See how VISFO’s precision intelligence and collaborative approach ensures you have the right insights, at the right time, to make the best possible strategic decisions.
Dashboard mockupiPhone mockup